SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-041615
Filing Date
2024-04-04
Accepted
2024-04-04 08:12:35
Documents
98
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F achl-20231231.htm   iXBRL 20-F 3664920
2 EX-4.7 achl-ex4_7.htm EX-4.7 26368
3 EX-4.9 achl-ex4_9.htm EX-4.9 209682
4 EX-8.1 achl-ex8_1.htm EX-8.1 9007
5 EX-12.1 achl-ex12_1.htm EX-12.1 28641
6 EX-12.2 achl-ex12_2.htm EX-12.2 28746
7 EX-13.1 achl-ex13_1.htm EX-13.1 7195
8 EX-13.2 achl-ex13_2.htm EX-13.2 6606
9 EX-15.1 achl-ex15_1.htm EX-15.1 4411
10 EX-97 achl-ex97.htm EX-97 41786
11 GRAPHIC img44182277_0.jpg GRAPHIC 22645
12 GRAPHIC img44182277_1.jpg GRAPHIC 42386
13 GRAPHIC img44182277_2.jpg GRAPHIC 44481
14 GRAPHIC img44182277_3.jpg GRAPHIC 95246
15 GRAPHIC img44182277_4.jpg GRAPHIC 333462
16 GRAPHIC img44182277_5.jpg GRAPHIC 27776
17 GRAPHIC img44182277_6.jpg GRAPHIC 312126
18 GRAPHIC img44182277_7.jpg GRAPHIC 54373
19 GRAPHIC img44182277_8.jpg GRAPHIC 69198
20 GRAPHIC img44182277_9.jpg GRAPHIC 37351
21 GRAPHIC img44182277_10.jpg GRAPHIC 14060
22 GRAPHIC img44182277_11.jpg GRAPHIC 205731
23 GRAPHIC img44182277_12.jpg GRAPHIC 80633
24 GRAPHIC img131018341_0.jpg GRAPHIC 199196
  Complete submission text file 0000950170-24-041615.txt   14518925

Data Files

Seq Description Document Type Size
25 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT achl-20231231.xsd EX-101.SCH 1315694
102 EXTRACTED XBRL INSTANCE DOCUMENT achl-20231231_htm.xml XML 1581424
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-40299 | Film No.: 24821696
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)